Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESOn July 5, IQVIA and Correo Farmacéutico celebrated a forum in Madrid entitled: "Connect with the customer: beyond the multichannel".
More than 60 professionals from different companies such as ADAMED, Allergan, Arkopharma, Cofares, Esteve, Dentaid, Faes Farma, Gilead, GSK, Inmunotek, Johnson & Johnson, MSD, Norgine, Normon, Mylan, Pfizer, Uriach, Vidal, Reig Jofre, Pharmalink and Zambon attended to the event.
The objective of the forum was to help laboratories understand the challenges to successfully address new ways of connecting and relating to the public in a comprehensive manner.
The agenda focused on three blocks, the first one "Digital transformation in the pharmaceutical industry" in which Pablo Foncillas, Professor and Researcher in Business Innovation, explained how digital disruption is transforming commercial models in the pharmaceutical industry and affirm that all customers are onmichannel in the way of thinking and behave, so sellers should be too.
The second block was a round table moderated by Karen Ticozzi, Director of Multichannel Strategy at IQVIA. At the table, experts from different laboratories such as Roche, Teva, Novartis and Grünenthal discussed the new profile to successfully face a multichannel strategy, the relationship with the client as a new approach and the digital transformation throughout the laboratory. All participants agreed that delegates should adapt to the new channels and they’re doing it.
Finally, Julio Portabella, Technology Director of IQVIA Spain and David Sierra, Technology Engagement Mgr of IQVIA Spain, presented a living example of a multichannel commercial strategy.
The forum was broadcast via Twitter using the hashtag #MulticanalidadCF.